UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by HCR Wealth Advisors

HCR Wealth Advisors lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,186 shares of the healthcare conglomerate’s stock after selling 79 shares during the period. HCR Wealth Advisors’ holdings in UnitedHealth Group were worth $1,106,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. International Assets Investment Management LLC grew its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Lone Pine Capital LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $480,903,000. Accredited Investors Inc. raised its position in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares in the last quarter. Raymond James & Associates boosted its holdings in shares of UnitedHealth Group by 33.1% in the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its holdings in UnitedHealth Group by 129.7% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.1 %

UnitedHealth Group stock opened at $543.21 on Thursday. The firm’s 50 day moving average price is $554.45 and its two-hundred day moving average price is $563.12. The firm has a market cap of $499.91 billion, a PE ratio of 35.39, a P/E/G ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm earned $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Cantor Fitzgerald lifted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays raised their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.